| Kenya | Malawi | South Africa | Tanzania | Uganda | Zimbabwe | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Round 1 | Round 2 | Round 1 | Round 2 | Round 1 | Round 2 | Round 1 | Round 2 | Round 1 | Round 2 | Round 1 | Round 2 |
Number of facilities | N = 38 | N = 40 | N = 5 | N = 5 | N = 23 | N = 23 | N = 15 | N = 15 | N = 19 | N = 18 | N = 15 | N = 35 |
Availability of ART guidelines in the facility (n(%)) | 33 (86.8) | 40 (100.0) | 3 (60.0) | 4 (80.0) | 23 (100.0) | 23 (100.0) | 15 (100.0) | 15 (100.0) | 16 (84.2) | 18 (100.0) | 6 (40.0) | 28 (80.0) |
Supervisory visits conducted at least once a year (n(%)) | 36 (94.7) | 39 (97.5) | 4 (80.0) | 5 (100.0) | 21 (91.3) | 23 (100.0) | 14 (93.3) | 14 (93.3) | 18 (94.7) | 18 (100.0) | 15 (100.0) | 33 (94.3) |
First-line ART is in stock (n(%)) | 31 (81.6) | 37 (92.5) | 4 (80.0) | 5 (100.0) | 20 (87.0) | 20 (87.0) | 10 (66.7) | 10 (66.7) | 16 (84.2) | 15 (83.3) | 14 (93.3) | 35 (100.0) |
ART regimens containing TDF with EFV is in stock (n(%)) | 4 (10.5) | 29 (72.5) | 5 (100.0) | 5 (100.0) | 21 (91.3) | 23 (100.0) | 2 (13.3) | 11 (73.3) | 12 (63.2) | 17 (94.4) | 4 (26.7) | 33 (94.3) |
IPT is in stock (n(%)) | 22 (57.9) | 37 (92.5) | 5 (100.0) | 4 (80.0) | 20 (87.0) | 23 (100.0) | 2 (13.3) | 2 (13.3) | 0 (0.0) | 2 (11.1) | 8 (53.3) | 15 (42.9) |
CTX is in stock (n(%)) | 38 (100.0) | 40 (100.0) | 5 (100.0) | 5 (100.0) | 21 (91.3) | 22 (95.7) | 9 (60.0) | 6 (40.0) | 19 (100.0) | 19 (100.0) | 33 (91.7) | 34 (97.1) |